ST14 anticorps (AA 566-855)

N° du produit ABIN7171018

Détail du produit anti-ST14 anticorps

Antigène: ST14 (Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14))

Épitope: AA 566-855

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp ST14 est non-conjugé

Application: ELISA, Immunohistochemistry (IHC)

Réactivité croisée: Humain

Purification: Antigen Affinity purified

Immunogène: Recombinant Human Suppressor of tumorigenicity 14 protein (566-855AA)

Isotype: IgG

Information d'application

Indications d'application: Recommended dilution: IHC:1:20-1:200,

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur ST14

Antigène: ST14 (Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14))

Autre désignation: ST14 (ST14 Produits)

Synonymes: anticorps HAI, anticorps MT-SP1, anticorps MTSP1, anticorps PRSS14, anticorps SNC19, anticorps TADG15, anticorps TMPRSS14, anticorps XMT-SP1, anticorps hai, anticorps mt-sp1, anticorps mtsp1, anticorps prss14, anticorps snc19, anticorps st14, anticorps st14a, anticorps tadg15, anticorps tmprss1, anticorps Epithin, anticorps Prss14, anticorps Tmprss14, anticorps mCAP3, anticorps matriptase, anticorps suppression of tumorigenicity 14, anticorps suppression of tumorigenicity 14 L homeolog, anticorps suppression of tumorigenicity 14 (colon carcinoma), anticorps ST14, anticorps st14.L, anticorps St14

Sujet:

Background: Degrades extracellular matrix. Proposed to play a role in breast cancer invasion and metastasis. Exhibits trypsin-like activity as defined by cleavage of synthetic substrates with Arg or Lys as the P1 site. Involved in the terminal differentiation of keratinocytes through prostasin (PRSS8) activation and filaggrin (FLG) processing.

Aliases: Epithin antibody, HAI antibody, Matriptase antibody, Membrane type serine protease 1 antibody, Membrane type serine protease antibody, Membrane-type serine protease 1 antibody, MT SP1 antibody, MT-SP1 antibody, MTSP 1 antibody, MTSP1 antibody, Prostamin antibody, PRSS 14 antibody, PRSS14 antibody, Serine protease 14 antibody, Serine protease TADG 15 antibody, Serine protease TADG-15 antibody, Serine protease TADG15 antibody, SNC 19 antibody, SNC19 antibody, ST 14 antibody, ST14 antibody, ST14_HUMAN antibody, Suppression of tumorigenicity 14 (colon carcinoma matriptase epithin) antibody, Suppression of tumorigenicity 14 (colon carcinoma) antibody, Suppression of tumorigenicity 14 antibody, Suppressor of tumorigenicity 14 protein antibody, Suppressor of tumorigenicity protein 14 antibody, TADG 15 antibody, TADG15 antibody, TMPRSS14 antibody, Tumor associated differentially expressed gene 15 protein antibody, Tumor-associated differentially-expressed gene 15 protein antibody

UniProt: Q9Y5Y6